Clinical outcome with low-dose valacyclovir in high-risk renal transplant recipients: A 10-year experience

11Citations
Citations of this article
23Readers
Mendeley users who have this article in their library.

Abstract

Background. Cytomegalovirus (CMV) remains an important pathogen in transplant patients, and valacyclovir (VACV) prophylaxis 8 g/day has been used in high-risk CMV-seromismatched [D+/R-] renal transplant patients to decrease CMV disease. Neurotoxic adverse effects have limited its use, and the aim of the present study was to retrospectively evaluate low-dose VACV prophylaxis, 3 g/day for 90 days after transplantation, in 102 D+/R- renal transplant patients. Methods. We compared patient and graft survival rates up to 5 years after transplantation with the data from the Collaborative Transplant Study Group (CTS) database. The incidence of CMV disease, rejection and neurotoxic adverse effects was analyzed up to 1 year after transplantation. Results. The patient and graft survival rates up to 5 years were comparable with those derived from the CTS. CMV disease was diagnosed in 25% of the patients and 2% developed tissue-invasive CMV disease. The rejection frequency was 22% and neurotoxic adverse effects were seen in 2% of the patients. Conclusion. sLow-dose VACV prophylaxis (3 g/day) for 90 days post-transplantation results in high patient and graft survival rates and reduces the incidence of CMV disease. Neurotoxic adverse effects are minimal. We believe that low-dose VACV prophylaxis should be considered to form one of the arms in future prospective comparison studies for the prevention of CMV disease in the high-risk D+/R- population of renal transplant patients. © 2012 © The Author 2012. Published by Oxford University Press on behalf of ERA-EDTA.

Cite

CITATION STYLE

APA

Sund, F., Tufveson, G., Döhler, B., Opelz, G., & Eriksson, B. M. (2013). Clinical outcome with low-dose valacyclovir in high-risk renal transplant recipients: A 10-year experience. Nephrology Dialysis Transplantation, 28(3), 758–765. https://doi.org/10.1093/ndt/gfs531

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free